Alseroxylon

Alseroxylon
	Reserpine, the major component of alseroxylon
Clinical data
ATC code	C02AA03 (WHO) ;
Identifiers
CAS Number	8001-95-4 ;
DrugBank	DB00386 ;
ChemSpider	None;
UNII	H192N84N1G;
ChEMBL	ChEMBL1201454 ;
Chemical and physical data
Formula	Varies
	(what is this?) (verify)

Alseroxylon (Rautensin, Rauwiloid) is a norepinephrine reuptake inhibitor that has been investigated in the treatment of hypertension[1] and angina pectoris and as a sedative in psychoses.[2] It was at one time approved for use in the United States, but has since been discontinued.[3]

Alseroxylon is a purified fat-soluble extract of the root of Rauvolfia serpentina, containing reserpine and other nonadrenolytic amorphous alkaloids.[2]

References

Green RS, Davolos D (May 1956). "A long-term study of the effect of crude Rauwolfia serpentina and of its alseroxylon fraction in patients with hypertension". The American Journal of Medicine. 20 (5): 760–73. doi:10.1016/0002-9343(56)90158-9. PMID 13313574.
DrugBank DB00386
Approved Drug Products with Therapeutic Equivalence Evaluations. FDA Orange Book (33rd ed.). 2013.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[1] Green RS, Davolos D (May 1956). "A long-term study of the effect of crude Rauwolfia serpentina and of its alseroxylon fraction in patients with hypertension". The American Journal of Medicine. 20 (5): 760–73. doi:10.1016/0002-9343(56)90158-9. PMID 13313574.

[DrugBank-2] DrugBank DB00386

[3] Approved Drug Products with Therapeutic Equivalence Evaluations. FDA Orange Book (33rd ed.). 2013.